Von Willebrand Disease Treatment

Von Willebrand Disease: An Inherited Bleeding Disorder Explained

Von Willebrand disease is an inherited bleeding disorder in which the blood contains too little von Willebrand factor, or the factor is present but does not work properly. Von Willebrand factor is a protein that helps platelets attach to damaged blood vessel walls and also carries and protects clotting factor VIII. When it is low or faulty, bleeding takes longer to stop — particularly from mucous membranes such as the nose, mouth, uterus and gastrointestinal tract. The condition affects both men and women, ranges from mild to severe, and is usually manageable once the type is understood and a plan is in place.

Many people live with von Willebrand disease for years without a clear diagnosis. Some first notice unusually heavy menstrual periods, frequent nosebleeds, easy bruising, prolonged bleeding after dental work, or unexpected bleeding after surgery. Others learn about the condition only after a child, sibling or parent is evaluated. The questions that follow are practical ones. Is the bleeding normal? Is surgery safe? What should happen before pregnancy or delivery? Should other family members be tested?

Answering those questions begins with specialist haematology care. The aim is not only to respond to bleeding episodes when they occur, but to anticipate them: to prevent avoidable complications during dental care, surgery, childbirth, trauma and everyday life. When the type and severity of von Willebrand disease are known, bleeding risk can be planned for rather than discovered at the worst possible moment.

At Acibadem, care for von Willebrand disease is led by physicians experienced in bleeding disorders and supported by laboratory diagnostics, multidisciplinary consultation where needed, and individualised treatment planning. This page explains what the condition is, how it is classified, how it is diagnosed and treated, and what living with it involves day to day.

What Is Von Willebrand Disease?

Von Willebrand disease, usually shortened to VWD, is a lifelong condition caused by a problem with a single blood protein: von Willebrand factor. In healthy blood, this factor performs two jobs. First, it acts as a molecular glue, helping platelets stick to the wall of an injured vessel and to each other, forming the initial plug that stops bleeding. Second, it binds clotting factor VIII and protects it from being broken down too quickly, keeping the wider clotting system supplied. When von Willebrand factor is reduced or dysfunctional, both jobs suffer, and the result is bleeding that starts easily and stops slowly.

Because the platelet plug forms first at mucosal surfaces, the typical bleeding pattern in VWD is mucocutaneous: nosebleeds, gum bleeding, easy bruising, heavy menstrual bleeding and prolonged oozing after cuts, dental extractions and surgery. Deep joint and muscle bleeds — the hallmark of severe clotting factor disorders — are less typical, although they can occur in the most severe forms of VWD when factor VIII is also very low.

What causes von Willebrand disease?

Von Willebrand disease is caused by changes in the gene that tells the body how to make von Willebrand factor. Depending on the specific change, the body may produce too little of the protein, produce a version that does not function correctly, or produce almost none at all. These genetic changes are usually passed down through families, which is why a careful family history is part of every evaluation. Much more rarely, an acquired form — acquired von Willebrand syndrome — develops later in life in association with certain other conditions, including some heart valve problems and aortic diseases, some blood and immune conditions, and an underactive thyroid. The acquired form is managed differently, because addressing the underlying condition is part of the plan, so distinguishing it from the inherited disease matters.

Is von Willebrand disease genetic?

Yes — in almost all cases von Willebrand disease is genetic and inherited. Most types pass through families in an autosomal dominant pattern, meaning a single altered copy of the gene, from either parent, is enough to cause the condition. Type 3, the most severe form, usually requires an altered gene copy from both parents, which is why it can appear in a child whose parents have few or no symptoms themselves. Severity varies considerably even within one family: a parent with barely noticeable bruising can have a child who bleeds far more obviously, and the reverse is also true. Occasionally the genetic change arises new, in a person with no family history at all. Because inheritance is central to the condition, a diagnosis in one person often prompts a discussion about whether children, siblings or parents should be tested.

How common is von Willebrand disease?

Von Willebrand disease is generally considered the most common inherited bleeding disorder worldwide. It occurs in every ethnic background and in both sexes, although women are diagnosed more often because menstruation and childbirth expose the bleeding tendency in ways daily life may not. Mild cases frequently go unrecognised — heavy periods are dismissed as normal, bruising is put down to clumsiness, nosebleeds are blamed on dry air — so the number of people living with the condition is likely higher than the number who carry a diagnosis. Severe forms such as Type 3 are rare, and most people with VWD have the milder Type 1.

Is von Willebrand disease a type of hemophilia?

No — von Willebrand disease is not a type of hemophilia, although the two are related and often confused. Hemophilia is caused by a deficiency of clotting factor VIII (hemophilia A) or factor IX (hemophilia B); it is linked to the X chromosome, causes symptoms predominantly in males, and typically produces joint and muscle bleeding. Von Willebrand disease is caused by a problem with von Willebrand factor, affects both sexes, and typically causes mucosal bleeding such as nosebleeds and heavy periods. There is one point of genuine overlap: because von Willebrand factor protects factor VIII, some people with VWD also have low factor VIII, and one subtype — Type 2N — can closely mimic mild hemophilia A on routine testing. Specialised laboratory assays separate the two conditions, and the distinction matters because treatment differs.

Other names you may see for von Willebrand disease

You may see the condition written as VWD disorder, v w disease, von disease, or even the misspelling willbran — all of these refer to the same diagnosis, von Willebrand disease, named after Erik von Willebrand, the Finnish physician who first described it. Among inherited bleeding disorders von Willebrand disease is by far the most frequently diagnosed, so most searches that combine bleeding symptoms with the name von Willebrand lead here. Whichever spelling brought you to this page, the medical facts are the same, and the sections below apply equally.

Types of Von Willebrand Disease

Von Willebrand disease is not a single condition. It is classified into three main types, and the type shapes both the likely bleeding pattern and the treatment options that will work.

Type 1 is the most common form. Von Willebrand factor levels are lower than normal, but the protein that is present usually works correctly. This is a quantity problem rather than a quality problem. Bleeding tends to be mild to moderate, and many people with Type 1 need treatment only around dental work, surgery, childbirth or heavy menstrual bleeding.

Type 2 is a quality problem: the amount of von Willebrand factor may be adequate or somewhat reduced, but the protein does not function normally. Type 2 is divided into subtypes with different mechanisms and different treatment implications. In Type 2A, the factor cannot form the large multimers needed for effective platelet binding. In Type 2B, the factor binds platelets too eagerly, which can reduce the platelet count and makes certain treatments, including desmopressin, potentially unsuitable. In Type 2M, the factor binds platelets poorly despite normal multimers. In Type 2N, the factor cannot hold on to factor VIII, so factor VIII levels drop and the picture can imitate mild hemophilia A. Identifying the exact subtype requires specialised testing, and it is worth the effort, because it changes the treatment plan.

Type 3 is the rarest and usually the most severe form. Von Willebrand factor is extremely low or effectively absent, and factor VIII is often very low as well. People with Type 3 can experience serious mucosal bleeding and, unlike milder types, joint and muscle bleeding. They typically need von Willebrand factor replacement therapy and ongoing specialist care rather than occasional, event-based treatment.

Because VWD ranges from barely detectable to severe, one person’s experience may be very different from another’s, even within the same family. Accurate classification is essential: a therapy that suits Type 1 may be less appropriate — or unsuitable — for Type 2B or Type 3. This is why diagnosis is not complete when the name of the condition is known; it is complete when the type is known.

Symptoms of Von Willebrand Disease: Who May Need Evaluation

Evaluation for von Willebrand disease is usually considered when bleeding is more frequent, heavier or longer-lasting than expected — a pattern that is easy to overlook because each individual episode can seem unremarkable. Common signs include:

• Frequent or prolonged nosebleeds
• Easy bruising, or bruises larger than the injury seems to justify
• Bleeding from the gums, especially after brushing or dental cleaning
• Prolonged bleeding after tooth extraction or minor cuts
• Excessive or unexpected bleeding during or after surgery
• Heavy or prolonged menstrual periods
• Anaemia related to ongoing blood loss
• Significant bleeding after childbirth

In more severe forms, joint or muscle bleeding can occur, although this is more typical of severe VWD or of other clotting factor disorders. Some patients simply report that cuts take a long time to stop bleeding, or that they have needed repeated medical attention after injuries that seemed minor.

What happens if you have von Willebrand disease?

If you have von Willebrand disease, your blood forms clots more slowly than usual, so bleeding episodes last longer and situations that stress the clotting system — surgery, dental extraction, childbirth, injury — carry a higher bleeding risk than they would otherwise. For most people the condition is episodic rather than constant: weeks or months may pass without any symptom, and then a nosebleed, a heavy period or a procedure brings it to the surface. Over time, repeated blood loss can quietly deplete iron stores, causing fatigue, reduced concentration and breathlessness on exertion even before anaemia appears on a blood count. What the diagnosis changes, above all, is preparation: once VWD is known, procedures can be planned, medicines reviewed, and bleeding treated promptly rather than reactively.

Von Willebrand disease in women

Women often carry the heaviest symptom burden. Heavy menstrual bleeding — periods that last long, soak through protection quickly, or produce large clots — is one of the most common presentations of VWD, and one of the most commonly normalised. When a mother and grandmother had the same periods, a family may assume the pattern is simply hereditary heaviness rather than a hereditary bleeding disorder, which of course it may be in a different sense. Adolescents can struggle particularly in the first years of menstruation. Pregnancy and childbirth deserve specific attention: von Willebrand factor levels usually rise during pregnancy, which can be protective, but they fall quickly after delivery, creating a window of risk for delayed postpartum bleeding. Iron deficiency, with or without frank anaemia, is a frequent companion of untreated heavy menstrual bleeding and deserves treatment in its own right.

Von Willebrand disease in children

Children with VWD may show frequent nosebleeds, easy bruising in unusual places, gum bleeding, or prolonged bleeding after a fall, a tooth extraction or a tonsillectomy. Because young children bruise as part of normal life, interpretation requires experience, and testing in early childhood sometimes needs to be repeated as the child grows. A child’s diagnosis frequently prompts testing of parents and siblings, since the condition is inherited. Planning matters at this age too: common childhood operations such as tonsillectomy and adenoidectomy are exactly the situations where an unrecognised bleeding disorder becomes apparent.

How Von Willebrand Disease Is Diagnosed

Von Willebrand disease is diagnosed through a combination of a detailed bleeding history and a panel of specialised blood tests, interpreted together by a haematologist — no single test result defines the condition on its own. The process usually moves through several steps:

1. Bleeding history. The haematologist asks about personal bleeding episodes, surgeries, dental procedures, menstrual history, pregnancies, medications, supplements and family history. Patients are asked to describe bleeding in practical terms: how long it lasted, whether medical treatment was needed, whether anaemia occurred, whether daily life was disrupted. Structured bleeding-assessment questionnaires are sometimes used to make this comparison objective.
2. Screening tests. A complete blood count, iron studies and standard coagulation screening tests establish the general picture and can reveal anaemia or a low platelet count.
3. Specific von Willebrand tests. Von Willebrand factor antigen measures how much of the protein is present; von Willebrand factor activity assays measure how well it works; and a factor VIII level shows whether the protective function is intact.
4. Classification tests. When the initial results point to VWD, additional assays — multimer analysis, ristocetin-induced platelet aggregation studies, factor VIII binding tests and, in selected cases, genetic testing — identify the type and subtype and distinguish VWD from other platelet or clotting disorders.
5. Confirmation. Because levels fluctuate, borderline or unexpected results are usually repeated before a diagnosis is confirmed or excluded.

Why might testing need to be repeated?

Testing often needs to be repeated because von Willebrand factor is not a fixed number: levels rise with stress, inflammation, infection, exercise, pregnancy and some hormonal therapies, and they vary naturally between individuals. A test taken during an illness or shortly after a stressful event can look temporarily normal in someone who genuinely has VWD. Blood group also matters — people with blood type O naturally run lower von Willebrand factor levels — and the haematologist takes this into account when interpreting results. For these reasons, physicians often prefer to test when the patient is well and not in the middle of a major physiological change, unless urgent decisions are needed. A careful, sometimes repeated, laboratory pathway protects against both underdiagnosis and overdiagnosis.

Patients seeking evaluation — before planned surgery, before fertility treatment or pregnancy, after a child’s diagnosis, or after unexpected bleeding from a previous procedure — can help the process considerably by gathering prior laboratory results, operative reports, transfusion records, current medication lists and any relevant family medical history. Old results are often as informative as new ones, because they show how factor levels have behaved over time.

Situations Von Willebrand Disease Management Covers

Managing von Willebrand disease is not limited to treating active bleeding. It is a preventive, planning-based approach that supports safer medical care and daily life, and a patient may need haematology input in many situations even when symptoms are mild.

Care commonly addresses heavy menstrual bleeding, iron deficiency anaemia, recurrent nosebleeds, bleeding after dental work, perioperative bleeding risk, pregnancy and delivery planning, postpartum bleeding prevention, trauma-related bleeding, and preparation for invasive diagnostic procedures such as endoscopy with biopsy. It also includes guidance about medicines that can increase bleeding risk — aspirin, certain anti-inflammatory drugs and some supplements among them. Whether any such medicine is appropriate for you is a decision that belongs with your treating doctor, who can weigh the bleeding risk against the reason the medicine was prescribed.

The shape of care changes with age and circumstance. Children with suspected VWD need a different approach from adults, particularly around tonsillectomy, dental extraction, sports participation and emergency preparedness. Adolescents may need support during the first years of menstruation. Adults may need a long-term plan covering surgery, pregnancy, chronic anaemia, or other health conditions that complicate bleeding management. In severe VWD, ongoing specialist follow-up is important to reduce the risk of serious bleeding and to ensure that appropriate therapy is available quickly when it is needed.

How Von Willebrand Disease Is Treated

Von Willebrand disease is treated with medicines that raise or replace von Willebrand factor, medicines that stabilise clots once they form, and — just as importantly — careful planning before procedures and high-risk life events, all matched to the patient’s type and severity. It is a lifelong condition that is managed rather than eliminated, and for many people management is intermittent: treatment around specific events rather than continuous therapy.

Preparation and medical review

The care pathway begins with assessment rather than immediate treatment. The haematology team reviews symptoms, family history, previous procedures, bleeding complications, transfusions, current medicines and prior laboratory results, then completes or repeats the diagnostic work-up described above. Only when the type and severity are clear does treatment planning begin, because the type determines which of the options below are suitable. Some patients leave this stage needing nothing more than education and a written plan for emergencies and procedures; others need active therapy.

Desmopressin

Desmopressin is a medicine that prompts the body to release its own stored von Willebrand factor from the lining of blood vessels. It can work well in many patients with Type 1 and in some with Type 2, but the response varies from person to person, so a supervised trial — with blood tests before and after a dose — is usually performed once, in a calm setting, to establish whether it works for that individual before it is relied upon. Desmopressin is generally not used in Type 2B, where it can worsen the platelet problem, and it is used cautiously or avoided in very young children, in patients with fluid-balance concerns, and in some patients with cardiovascular or cardiometabolic disorders. It is also less useful when treatment must continue for many days, because the body’s stores of factor need time to replenish.

Von Willebrand factor replacement concentrates

Von Willebrand factor concentrates supply the missing protein directly, by infusion. They are the mainstay for Type 3 disease, for many Type 2 patients, for major surgery, for serious bleeding, and for anyone in whom desmopressin is ineffective or not advised. Around operations, the haematologist defines target factor levels, doses and timing, and laboratory monitoring confirms that the targets are met — before the procedure and through the healing period, when a clot must hold while tissue repairs itself.

Antifibrinolytic medicines

Antifibrinolytic medicines, such as tranexamic acid, do not raise von Willebrand factor; instead they slow the natural breakdown of clots that have already formed. They are particularly useful for mucosal bleeding — mouth, nose and uterus — and around dental work, where they may be sufficient on their own for some patients with milder disease or may be combined with the treatments above.

Hormonal and gynaecological options

Hormonal therapies can reduce heavy menstrual bleeding in women with VWD, and some gynaecological treatments serve the same goal; the right choice depends on the patient’s age, plans for pregnancy, medical history and any coexisting hormonal disorders. These decisions sit at the border between haematology and gynaecology, which is one of the reasons coordinated, multidisciplinary care matters in this condition.

Iron replacement

When chronic blood loss has drained iron stores, oral iron supplementation or intravenous iron may be recommended alongside bleeding control. Treating the bleeding without treating the iron deficiency leaves patients tired for months longer than necessary; treating both together restores energy and exercise tolerance as stores rebuild.

Planning for surgery, dental care and procedures

When a patient with VWD needs surgery or an invasive procedure, planning is the treatment. The haematologist works with the surgeon, anaesthetist, dentist, obstetrician or other specialist to define the bleeding risk of the specific procedure and to build a perioperative plan: pre-procedure medication, factor level targets, dose timing, laboratory monitoring, and post-procedure treatment to keep the clot stable during healing. For minor dental work, antifibrinolytic medicine and local measures may be enough for some patients, while others need more. For major surgery, factor replacement and monitoring may continue for several days or longer. A good plan also states, in advance, what should happen if unexpected bleeding occurs after the patient has gone home — so that the response is decided before it is needed.

Pregnancy, birth and postpartum care

Pregnancy needs particular attention in VWD because von Willebrand factor levels usually rise through pregnancy and then fall quickly after delivery, creating a specific risk of delayed postpartum bleeding. A coordinated plan may involve haematology, obstetrics, anaesthesiology, neonatology and blood bank services, and covers delivery options, decisions about regional anaesthesia, factor monitoring, postpartum medication and — where the baby may have inherited the condition — newborn evaluation and precautions. Women with known or suspected VWD benefit from evaluation before conception or early in pregnancy, which leaves time to confirm the diagnosis, track factor levels and prepare the delivery and postpartum plan calmly rather than urgently.

How long does treatment take?

VWD care is rarely a single-day event, but it is not a permanent medical burden for most patients either. Initial evaluation involves consultation and laboratory testing, sometimes with a repeat visit for confirmation. A desmopressin trial, when appropriate, takes several hours, with blood tests before and after the dose. Treatment of a minor bleeding episode may be brief; support around major surgery or childbirth extends across the procedure and the healing period. For chronic problems such as heavy menstrual bleeding or iron deficiency, improvement builds over weeks to months as bleeding control takes effect and iron stores recover. Between events, most patients need only periodic follow-up and an up-to-date written plan.

Why Acting Early Matters

Early diagnosis and planning prevent avoidable complications. Many patients with undiagnosed VWD only discover the condition after a difficult surgery, severe postpartum bleeding, repeated dental bleeding or years of unexplained anaemia. When VWD is recognised beforehand, physicians can review medicines, prepare factor support and blood products where needed, and choose safer procedural strategies from the outset.

Delayed evaluation has quieter costs too. Untreated iron deficiency erodes energy, concentration and quality of life long before it becomes dramatic. Repeated heavy menstrual bleeding disrupts school, work, travel and social life. An unplanned operation performed without a bleeding plan raises the chance of prolonged bleeding, transfusion, reoperation or delayed healing — outcomes that planning exists to avoid.

For families, an early diagnosis in one person can guide testing for relatives. Because von Willebrand disease is inherited, identifying affected family members before their own procedures, pregnancies or injuries can be clinically important, and it turns a surprise into a known, manageable fact.

Benefits of Von Willebrand Disease Treatment and Management

The benefits of VWD care come from understanding the diagnosis precisely and using the right treatment at the right time.

Benefit	What It Means for You
Clear diagnosis and classification	You and your doctors understand the type of VWD, the likely bleeding risks, and which treatments are appropriate.
Safer surgery and dental care	Medication, laboratory monitoring, and procedural planning can be arranged before bleeding becomes an emergency.
Better control of heavy menstrual bleeding	Treatment may reduce blood loss, improve anaemia, and support daily activities, school, work, and travel.
Pregnancy and delivery planning	Haematology and obstetric teams can prepare for delivery, anaesthesia decisions, and postpartum bleeding prevention.
Emergency readiness	A written care plan helps physicians respond quickly after injury, unexpected bleeding, or urgent procedures.
Family awareness	Relatives who may also have VWD can be advised about testing and preventive planning when appropriate.

Recovery and Follow-Up Timeline

Because VWD management is individualised, the timeline depends on whether you are being diagnosed, treated for bleeding, or prepared for a procedure. The table below shows a typical shape of care.

Time Period	What Patients Can Expect
Day 1	Initial consultation may include bleeding history, medication review, family history, and blood tests. If urgent bleeding is present, treatment may begin immediately.
First Week	Laboratory results are reviewed. Some patients may need repeat or specialised testing, treatment adjustment, or a desmopressin response test.
First Month	A personalised bleeding plan is developed. For menstrual bleeding or iron deficiency, therapy is monitored and adjusted based on symptoms and lab results.
Before Procedures	The haematologist coordinates with the surgical, dental, obstetric, or anaesthesia team to define medication timing, factor targets, and follow-up monitoring.
Longer Term	Patients continue periodic follow-up, update their emergency plan, review new medications, and reassess needs before pregnancy, surgery, or major travel.

Living With Von Willebrand Disease

For most people, von Willebrand disease is a condition to plan around rather than a condition that defines daily life. The practical questions patients ask most often have reassuring, specific answers.

What is the life expectancy of someone with von Willebrand disease?

For most people, von Willebrand disease does not shorten life: the condition is compatible with a long, active and otherwise ordinary lifespan, particularly in the milder types that make up the great majority of cases. The realistic concerns are situational rather than constant — serious bleeding around surgery, childbirth or major trauma when the condition is unknown or unplanned for, and the slow wear of untreated anaemia on daily wellbeing. Severe forms such as Type 3 require closer, lifelong specialist care precisely so that these situational risks are contained. In practical terms, the diagnosis changes how medical events are prepared for, not how long life is expected to last.

What foods should you avoid with von Willebrand disease?

No food needs to be avoided because of von Willebrand disease itself, and no diet treats it — the condition is a protein problem, not a nutritional one. Two dietary points are still worth knowing. First, some over-the-counter supplements — high-dose fish oil, vitamin E, ginkgo and garlic extracts among them — may affect platelet function, so it is sensible to discuss any supplement with your treating doctor before taking it regularly. Second, a diet with adequate iron supports recovery when heavy bleeding has depleted iron stores, although diet alone rarely corrects an established deficiency, which is why iron replacement is prescribed when needed.

Everyday activity, sport and travel

Most people with VWD can work, study, exercise and travel normally. Sensible adjustments depend on severity: someone with mild Type 1 may need no restrictions at all, while a person with severe disease may be advised to prefer sports with lower collision risk. It helps to make sure that dentists, surgeons and other treating clinicians know about the diagnosis before any procedure, however minor it seems, and to carry written medical information when travelling — diagnosis, type, baseline test results, documented response to treatment and the current management plan — so that clinicians anywhere can act on accurate information. Patients who take medicines that affect clotting for other conditions, such as anticoagulants prescribed for heart rhythm disorders, need those medicines and the bleeding disorder managed together by their doctors, never adjusted independently.

Factors That Influence Outcomes

Good outcomes in von Willebrand disease start with an accurate diagnosis. The type of VWD, baseline factor levels, bleeding history, age, sex, blood group, pregnancy status, other medical conditions and current medicines all shape risk. A patient with mild Type 1 disease facing a small dental procedure needs a very different plan from a patient with Type 3 disease preparing for major surgery — and treating both with the same protocol would serve neither well.

The quality and timing of laboratory testing matter just as much. Because von Willebrand factor levels fluctuate, isolated results can mislead in either direction, and careful haematology interpretation protects against both underdiagnosis and overtreatment. In selected cases, repeat testing, family testing or specialised assays are needed before the picture is clear, and taking that time is usually the right call.

Communication among specialists is a third, often underestimated factor. Surgeons, dentists, obstetricians, anaesthetists, emergency physicians and family doctors all need to know that a patient has VWD and what the management plan says. Written documentation — diagnosis, type, baseline results, medication response and emergency recommendations — travels with the patient and keeps every clinician working from the same facts, wherever care is delivered.

Patient understanding closes the loop. People who know their own type, their documented treatment response, which medicines carry bleeding risk and how to prepare for procedures consistently fare better than those who carry only the name of the diagnosis. Women with heavy menstrual bleeding benefit from monitoring for iron deficiency even when haemoglobin is near normal, because depleted stores cause symptoms before anaemia becomes measurable. And complex situations — pregnancy, cancer surgery, liver disease, anticoagulant therapy, cardiovascular disease — shift the balance between bleeding and clotting, so decisions in these settings are best made through coordinated specialist review rather than a standard protocol applied to everyone.

Von Willebrand Disease Care at Acibadem

The value of a comprehensive hospital setting for a bleeding disorder is that haematology expertise connects directly with the other specialties the condition touches — gynaecology, paediatrics, anaesthesia, surgery, gastroenterology and emergency medicine among them. A diagnosis of von Willebrand disease rarely stays within one department: it shapes decisions about operations, deliveries, dental work and long-term follow-up, and those decisions go better when every specialist involved works from the same plan.

At Acibadem, patients with suspected or confirmed VWD are evaluated through haematology-led pathways that combine clinical assessment with laboratory diagnostics: coagulation analysis, von Willebrand factor antigen and activity assays, factor testing, platelet-related assessment and multimer analysis in selected cases. The point of the technology is not the test itself but its interpretation — results read by clinicians who understand inherited bleeding disorders, alongside the patient’s history rather than in isolation. When surgery, childbirth or another specialty procedure is involved, the haematology team coordinates with the relevant physicians to build an individualised perioperative plan.

A second opinion can also be structured around specific questions — whether the diagnosis is complete, whether the type is correctly classified, how previous bleeding history affects an upcoming procedure, and whether relatives, including children, should be tested and how they should be followed as they grow.

Preparing for a Haematology Consultation

Wherever an evaluation takes place, preparation improves it. The records that help a haematologist most are:

• Previous laboratory results, especially any von Willebrand factor or factor VIII measurements, with dates
• Operative and dental records, including any bleeding complications
• Transfusion history and any documented response to bleeding treatment
• Menstrual and obstetric history, where relevant
• A complete list of current medicines and supplements
• Family history of bleeding symptoms or diagnosed bleeding disorders

Von Willebrand disease is, for most people, a manageable condition — but manageable depends on the right diagnosis, the right classification and clear communication before higher-risk situations. With haematology-led evaluation and coordinated planning, patients can approach procedures, pregnancy, travel and daily life with better information, and living with VWD shifts from uncertainty to informed preparedness.